Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Dogliotti
Observed names:
DOGLIOTTI, IRENE,
Dogliotti Irene,
I. Dogliotti
Institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
University of Turin
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Azienda Sanitaria Unità Locale di Reggio Emilia,
Ospedale San Giovanni Bosco,
Policlinico San Matteo Fondazione,
Ospedale San Luigi Gonzaga,
University of Turin,
European Institute of Oncology
show all 7
ORCID:
0009-0004-0873-1622
Observed ORCID:
0009-0004-0873-1622
OpenAlex ID:
A5034136227
Highly sensitive MYD88 L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia
2018
·
Daniela Drandi
, Elisa Genuardi
, et al.
·
Haematologica
·
93
PDF
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
2019
·
Carmen Fava
, Giovanna Rege-Cambrin
, et al.
·
Haematologica
·
78
PDF
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
2022
·
Irene Dogliotti
, Cristina Jiménez
, et al.
·
Leukemia
·
63
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
2020
·
Ramón García‐Sanz
, Irene Dogliotti
, et al.
·
British Journal of Haematology
·
50
PDF
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience
2022
·
Alessandro Busca
, Natascia Cinatti
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
40
PDF
Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study
2023
·
Jessica Gill
, Alessandro Busca
, et al.
·
Microorganisms
·
35
PDF
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
2022
·
Michele Clerico
, Irene Dogliotti
, et al.
·
Journal of Clinical Medicine
·
35
PDF
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
2018
·
Irene Dogliotti
, Daniela Drandi
, et al.
·
Journal of Clinical Medicine
·
29
PDF
Update on emerging treatments for chronic myeloid leukemia
2015
·
Carmen Fava
, Alessandro Morotti
, et al.
·
Expert Opinion on Emerging Drugs
·
27
Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
2022
·
Mattia Parisi
, Irene Dogliotti
, et al.
·
European Journal of Neurology
·
21
PDF
ABVD vs BEACOPP escalated in advanced‐stage Hodgkin’s lymphoma: Results from a multicenter European study
2020
·
Patrizia Mondello
, Caterina Musolino
, et al.
·
American Journal of Hematology
·
20
PDF
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
2021
·
Martina Ferrante
, Daniela Furlan
, et al.
·
Diagnostics
·
19
PDF
Standardized IGH-Based Next-Generation Sequencing for MRD Detection in Follicular Lymphoma
2017
·
Christiane Pott
, Henrik Knecht
, et al.
·
Blood
·
19
CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report
2017
·
Irene Dogliotti
, Carmen Fava
, et al.
·
Stem Cell Investigation
·
19
PDF
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
2024
·
Irene Dogliotti
, Veronica Peri
, et al.
·
Cancer Medicine
·
18
PDF
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation
2024
·
Irene Dogliotti
, Mario Levis
, et al.
·
Cancers
·
17
PDF
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
2023
·
Manuel Gotti
, Roberta Sciarra
, et al.
·
HemaSphere
·
16
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor
2016
·
Carmen Fava
, Giovanna Rege-Cambrin
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
16
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
2020
·
Marzia Varettoni
, Angela Ferrari
, et al.
·
American Journal of Hematology
·
13
PDF
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
2022
·
Semra Aydin
, Roberto Passera
, et al.
·
International Journal of Hematology
·
12
PDF
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi
2021
·
Annalisa Arcari
, Lucia Morello
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
12
Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis
2017
·
E. Genuardi
, D. Barbero
, et al.
·
International Journal of Laboratory Hematology
·
10
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
2025
·
Shirley D'Sa
, Jahanzaib Khwaja
, et al.
·
Seminars in Hematology
·
9
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm
2025
·
Elena Crisà
, Irene Dogliotti
, et al.
·
Cancers
·
8
PDF
Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients
2023
·
Nour Shbaklo
, Costanza Vicentini
, et al.
·
Pharmaceuticals
·
8
PDF
Show more works
View as search
Works count:
90
Citation count:
794
H-index:
16
I10-index:
22
Year
Topic
Type